Summary of changes in the 2025 Canadian Urological Association/Canadian Urologic Oncology Group guideline on metastatic castration-resistant prostate cancer
Canadian Urological Association Journal · 28.07.2025 · 19 (8) · 228-9
DOI: 10.5489/cuaj.9359 ↗Kurz gefasst
Leitlinie in der Zeitschrift Canadian Urological Association Journal, online erschienen am 28.07.2025. Verfasst von Fred Saad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, Université de Montréal, Montreal, QC, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Urology, Department of Surgery, Université de Montréal, Montreal, QC, Canada.
- Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Zitieren
APA
Saad, F., & So, A. I. (2025). Summary of changes in the 2025 Canadian Urological Association/Canadian Urologic Oncology Group guideline on metastatic castration-resistant prostate cancer. Canadian Urological Association Journal, 19(8), 228-9. https://doi.org/10.5489/cuaj.9359
Vancouver
Saad F, So AI. Summary of changes in the 2025 Canadian Urological Association/Canadian Urologic Oncology Group guideline on metastatic castration-resistant prostate cancer. Canadian Urological Association Journal. 2025;19(8):228-9. doi:10.5489/cuaj.9359
BibTeX
@article{Saad2025,
author = {Saad, Fred and So, Alan I},
title = {Summary of changes in the 2025 Canadian Urological Association/Canadian Urologic Oncology Group guideline on metastatic castration-resistant prostate cancer},
journal = {Canadian Urological Association Journal},
year = {2025},
volume = {19},
number = {8},
pages = {228--9},
doi = {10.5489/cuaj.9359}
}
EUVIMED